3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Arterial Diseases, Carotid in 1 studies
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baudy, RB | 1 |
| Fletcher, H | 1 |
| Yardley, JP | 1 |
| Zaleska, MM | 1 |
| Bramlett, DR | 1 |
| Tasse, RP | 1 |
| Kowal, DM | 1 |
| Katz, AH | 1 |
| Moyer, JA | 1 |
| Abou-Gharbia, M | 1 |
1 other study available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Arterial Diseases, Carotid
| Article | Year |
|---|---|
Design, synthesis, SAR, and biological evaluation of highly potent benzimidazole-spaced phosphono-alpha-amino acid competitive NMDA antagonists of the AP-6 type.
Topics: Animals; Arterial Occlusive Diseases; Benzimidazoles; Binding, Competitive; Brain; Carotid Artery Di | 2001 |